LINC01625

Across TCGA pan-cancer cohorts, LINC01625 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated LINC01625 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC01625 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01625 expression acts as an unfavorable survival marker, although some lineages such as KIRP and LUAD show a favorable association.

BLCA, UCEC, and KIRP are the cancer types where LINC01625 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.293	0.518	<.001	156	view →
UCEC	DFS	Median	All	0.519	0.780	<.001	132	view →
KIRP	OS	Median	All	0.978	0.882	<.001	74	view →
CHOL	DFS	Quartile	II,III,IV	0.270	0.523	.001	68	view →
THCA	OS	Quartile	All	0.779	1.000	<.001	60	view →
KICH	OS	Quartile	II,III,IV	0.680	0.955	.007	48	view →
LUAD	DFS	Quartile	All	0.863	0.736	.002	37	view →
UCS	DFS	Quartile	II,III,IV	0.651	0.114	.001	32	view →
SARC	OS	Median	All	0.915	0.731	<.001	21	view →
COAD	DFS	Tertile	II,III,IV	0.680	0.771	.025	18	view →
LAML	DFS	Median	All	0.460	0.689	.017	12	view →
READ	DFS	Tertile	All	0.250	0.666	.013	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

LINC01625–BLCA (OS)

Open the BLCA breakdown →